Testosterone increases osteoprotegerin mRNA expression in mouse osteoblast cells.
The DOI matches its Crossref record.
Abstract
The role that androgens play in the regulation of bone metabolism has been substantiated in animals and humans. We previously demonstrated that testosterone inhibits osteoclast differentiation stimulated by parathyroid hormone through the androgen receptor in mouse bone-cell cultures. However, the details of this mechanism are still unknown. The present study was aimed at examining whether testosterone would affect the mRNA levels of osteoprotegerin (OPG) and receptor activator of Nf kappa B ligand (RANKL) in mouse bone-cell cultures as well as mouse osteoblastic cell-line, MC3T3-E1 cells by employing semi-quantitative RT-PCR. Testosterone increased OPG mRNA expression in both mouse bone-cell cultures and MC3T3-E1 cells. 10-8 M PTH-(1-34) as well as 10-8M 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] inhibited OPG mRNA expression in mouse bone cells. 10-8 M testosterone antagonized OPG mRNA expression inhibited by 10-8 M PTH-(1-34), but failed to affect OPG mRNA expression inhibited by 10-8 M 1,25(OH)2D3. 10-8 M alpha-dehydrotestosterone, a non-aromatizable androgen, increased OPG mRNA expression. On the other hand, testosterone did not affect RANKL mRNA expression in MC3T3-E1 or mouse bone cells. In conclusion, the present study demonstrated that testosterone increased OPG mRNA expression in mouse bone-cell cultures and the osteoblastic cell line. These effects are likely to take place through the androgen receptor.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Androgens have been shown to upregulate (218) and down-regulate (219) OPG expression in cultured osteoblasts, whereas RANKL was unregulated by androgens in both studies.”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [218]
Citations
Cites
Still being checked.
Cited by
Kearns, A. E., Khosla, S., & Kostenuik, P. J. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0014 · Cited by 824
Negre‐Salvayre, A., Coatrieux, C., Ingueneau, C., & Salvayre, R. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707395 · Cited by 641
RANK/RANKL: Regulators of Immune Responses and Bone Physiology
Leibbrandt, A., & Penninger, J. M. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1443.016 · Cited by 420
Intervention strategies to inhibit protein carbonylation by lipoxidation‐derived reactive carbonyls
Aldini, G., Dalle‐Donne, I., Facino, R. M., Milzani, A., & Carini, M. (2007) · Medicinal Research Reviews · doi:10.1002/med.20073 · Cited by 289
Michael, H., Härkönen, P. L., Väänänen, H. K., & Hentunen, T. A. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.050803 · Cited by 200
“growth factors, and cytokines in addition to E2, such as PTH,((69)) 1,25-dihydroxyvitamin D3, BMP-2, TNF- , IL1 ,((70)) and Te.((71))”
BackgroundGoëb, V., & Anne-Priscille, T. (2010) · Clinical Interventions in Aging · doi:10.2147/cia.s10153 · Cited by 179
Testosterone and Bone Health in Men: A Narrative Review
Shigehara, K., Izumi, K., Kadono, Y., & Mizokami, A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10030530 · Cited by 171
Genetic and Transcriptional Control of Bone Formation
Javed, A., Chen, H., & Ghori-Javed, F. Y. (2010) · Oral and Maxillofacial Surgery Clinics of North America · doi:10.1016/j.coms.2010.05.001 · Cited by 168
Regulation of adult bone turnover by sex steroids
Frenkel, B., Hong, A., Baniwal, S. K., Coetzee, G. A., Ohlsson, C., Khalid, O. S., & Gabet, Y. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22159 · Cited by 165
Sex Steroids and Stem Cell Function
Ray, R., Novotny, N. M., Crisostomo, P. R., Lahm, T., Abarbanell, A., & Meldrum, D. R. (2008) · Molecular Medicine · doi:10.2119/2008-00004.ray · Cited by 117
Sex hormones, their receptors and bone health
Venken, K., Callewaert, F., Boonen, S., & Vanderschueren, D. (2008) · Osteoporosis International · doi:10.1007/s00198-008-0609-z · Cited by 116
Bone Health in Adult Cancer Survivorship
Lustberg, M. B., Reinbolt, R. E., & Shapiro, C. L. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.42.2097 · Cited by 110
Aldini, G., Dalle‐Donne, I., Colombo, R., Facino, R. M., Milzani, A., & Carini, M. (2006) · ChemMedChem · doi:10.1002/cmdc.200600075 · Cited by 93
Stern, A., Laughlin, G. A., Bergstrom, J., & Barrett-Connor, E. L. (2007) · European Journal of Endocrinology · doi:10.1530/eje-06-0753 · Cited by 81
Hormonal Aspects of the Muscle-Bone Unit
Zofkova, I. (2008) · Physiological Research · doi:10.33549/physiolres.931501 · Cited by 79
The Role of Sex Differences in Bone Health and Healing
Ortona, E., Pagano, M. T., Capossela, L., & Malorni, W. (2023) · Biology · doi:10.3390/biology12070993 · Cited by 68
Li, X., Ominsky, M. S., Stolina, M., Warmington, K. S., Geng, Z., Niu, Q., Asuncion, F., Tan, H., Grisanti, M. S., Dwyer, D., et al. (2009) · Bone · doi:10.1016/j.bone.2009.06.011 · Cited by 69
An Overlooked Bone Metabolic Disorder: Cigarette Smoking-Induced Osteoporosis
Weng, W., Li, H., & Zhu, S. (2022) · Genes · doi:10.3390/genes13050806 · Cited by 65
“It has been shown that estrogen inhibits osteoclast differentiation and bone resorption [50], while testosterone promotes proliferation and osteogenic differentiation [51].”
BackgroundJankowska, E. A., Jakubaszko, J., Cwynar, A., Majda, J., Ponikowska, B., Kustrzycka−Kratochwil, D., Reczuch, K. W., Borodulin-Nadzieja, L., Banasiak, W., Poole-Wilson, P. A., et al. (2009) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfn004 · Cited by 65
Asirvatham, A. J., Schmidt, M. A., Gao, B., & Chaudhary, J. (2005) · Endocrinology · doi:10.1210/en.2005-0942 · Cited by 63
Sun, L., Pan, J., Peng, Y., Wu, Y., Li, J., Liu, X., Qin, Y., Bauman, W. A., Cardozo, C. P., Zaidi, M., et al. (2013) · Journal of Spinal Cord Medicine · doi:10.1179/2045772312y.0000000020 · Cited by 56
Chemistry of pyridoxine in drug design
Shtyrlin, Y. G., Petukhov, A. S., Strel'nik, A. D., Валерьевич, Ш. Н., Iksanova, A. G., Владимирович, П. М., Pavelyev, R. S., Dzyurkevich, M. S., Garipov, M. R., & Balakin, K. V. (2019) · Russian Chemical Bulletin · doi:10.1007/s11172-019-2504-5 · Cited by 56
Skeletal and extraskeletal actions of denosumab
Sinningen, K., Tsourdi, E. A., Rauner, M., Rachner, T. D., Hamann, C., & Hofbauer, L. C. (2012) · Endocrine · doi:10.1007/s12020-012-9696-x · Cited by 55
Miki, Y., Suzuki, T., Hatori, M., Igarashi, K., Aisaki, K., Kanno, J., Nakamura, Y., Uzuki, M., Sawai, T., & Sasano, H. (2006) · Bone · doi:10.1016/j.bone.2006.11.029 · Cited by 54
Androgens and bone growth: it's location, location, location
Wiren, K. M. (2005) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2005.06.003 · Cited by 52
Testosterone Regulates Bone Response to Inflammation
Steffens, J. P., Herrera, B. S., Coimbra, L. S., Stephens, D., Rossa, C., Spolidório, L. C., Kantarcı, A., & Dyke, T. E. V. (2014) · Hormone and Metabolic Research · doi:10.1055/s-0034-1367031 · Cited by 50
Biology and clinical management of prostate cancer bone metastasis
Ye, X.-C., Choueiri, M., Tu, S.-M., & Lin, S.-H. (2007) · Frontiers in bioscience · doi:10.2741/2311 · Cited by 40
Davidge-Pitts, C. J., & Clarke, B. L. (2019) · Maturitas · doi:10.1016/j.maturitas.2019.05.002 · Cited by 38
Gooren, L. J., Kreukels, B. P. C., Lapauw, B., & Giltay, E. J. (2014) · Andrologia · doi:10.1111/and.12389 · Cited by 37
Shuid, A. N., El-arabi, E., Effendy, N. M., Razak, H. S. A., Muhammad, N., Mohamed, N., & Soelaiman, I. N. (2012) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-12-152 · Cited by 36
Wang, J., Lu, K., Song, Y., Zhao, S., Ma, W., Xuan, Q., Tang, D., Zhao, H., Liu, L., & Zhang, Q. (2015) · PLoS ONE · doi:10.1371/journal.pone.0133964 · Cited by 35
Association of plasma GDF-9 or GDF-15 levels with bone parameters in polycystic ovary syndrome
Berberoğlu, Z., Aktas, A., Fidan, Y., Yazıcı, A. C., & Aral, Y. (2014) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-013-0560-8 · Cited by 33
Lee, H., Finkelstein, J. S., Miller, M. E., Comeaux, S. J., Cohen, R., & Leder, B. Z. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2495 · Cited by 32
Kwilas, A. R., Ardiani, A., Gameiro, S. R., Richards, J., Hall, A. B., & Hodge, J. W. (2016) · Oncotarget · doi:10.18632/oncotarget.8274 · Cited by 31
Kim, C. S., Bae, E. H., Kwon, S., Han, S. H., Choi, K. H., Lee, J., Chae, D., Oh, K., Ahn, C., Kim, S. W., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166792 · Cited by 23
Angelopoulos, N., Goula, A., Katounda, E., Rombopoulos, G., Kaltzidou, V., Kaltsas, D., Malaktari, S., Athanasiou, V., & Tolis, G. (2006) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-006-0728-6 · Cited by 23
Radanović, M. M., Vojinović‐Ješić, L. S., Jovanović, L. S., Leovac, V. M., Češljević, V. I., & Divjaković, V. (2012) · Inorganica Chimica Acta · doi:10.1016/j.ica.2012.03.026 · Cited by 22
The multi-faceted role of retinoid X receptor in bone remodeling
Menéndez-Gutierrez, M. P., & Ricote, M. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2458-4 · Cited by 21
Serum osteoprotegerin concentrations are decreased in women with the polycystic ovary syndrome
Escobar-Morreale, H. F., Botella-Carretero, J. I., Martínez-García, M. Á., Luque‐Ramírez, M., Álvarez‐Blasco, F., & Millán, J. L. S. (2008) · European Journal of Endocrinology · doi:10.1530/eje-08-0107 · Cited by 21
Florence, G. E., Oosthuyse, T., & Bosch, A. N. (2023) · Journal of Sports Sciences · doi:10.1080/02640414.2024.2312052 · Cited by 17
Radanović, M. M., Jovanović, L. S., Vojinović‐Ješić, L. S., Leovac, V. M., Češljević, V. I., Rodić, M. V., & Divjaković, V. (2012) · Journal of Coordination Chemistry · doi:10.1080/00958972.2012.737916 · Cited by 17
Abo-Aziza, F., Zaki, A. K. A., Amer, A., & Lotfy, R. A. (2019) · International Journal of Hematology-Oncology and Stem Cell Research · doi:10.18502/ijhoscr.v13i4.1897 · Cited by 15
Wiren, K. M., & ORWOLL, E. S. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374602-3.00025-0 · Cited by 15
Yang, J., Kong, G., Yao, X., & Zhu, Z. (2022) · International Journal of Endocrinology · doi:10.1155/2022/4228740 · Cited by 14
Modifying RANKL/OPG mRNA Expression in Differentiating and Growing Human Primary Osteoblasts
Giner, M., Montoya-García, M.-J., Vázquez, M. Á., Rios, M., Moruno, R., Miranda, M., & Pérez‐Cano, R. (2008) · Hormone and Metabolic Research · doi:10.1055/s-0028-1082083 · Cited by 13
Kalyanaraman, H., China, S. P., Casteel, D. E., & Pilz, R. B. (2025) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2025.01.007 · Cited by 11
Gao, K., Wang, X., Liu, Q., Chen, W., Wang, G., Zhang, D., & Liu, L. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26566 · Cited by 11
Molecular Cross-Talk Between Nuclear Receptors and Nuclear Factor-κB
Beck, I. M. E., Haegeman, G., & Bosscher, K. D. (2010) · Springer eBooks · doi:10.1007/978-90-481-9531-2_10 · Cited by 9
Androgen Receptor Expression and Function in Osteoclasts
Turner, A. G., Notini, A. J., Chiu, W. S. M., Hodge, J. M., Nicholson, G. C., Zajac, J. D., & Davey, R. A. (2008) · The Open Physiology Journal · doi:10.2174/1874360900801010028 · Cited by 8
Diagnosis and therapeutic approach to bone health in patients with hypopituitarism
Kuliczkowska-Płaksej, J., Zdrojowy-Wełna, A., Jawiarczyk-Przybyłowska, A., Gojny, Ł., & Bolanowski, M. (2024) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-024-09878-w · Cited by 6
Yoshida, T., Wang, J., & Stern, P. H. (2019) · Handbook of experimental pharmacology · doi:10.1007/164_2019_327 · Cited by 6
Insight into Bone Metabolism and Skeletal Mass in Polycystic Ovary Syndrome
Berberoğlu, Z. (2015) · EMJ Reproductive Health · doi:10.33590/emjreprohealth/10311026 · Cited by 5
Androgens Receptor Expression and Steroid Action in Bone
Wiren, K. M. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373884-4.00062-8 · Cited by 4
Proteinglykierung als pathophysiologischer Mechanismus bei Diabetes
Simm, A., Santos, A. N., Hofmann, B., Bushnaq, H. S., & Naß, N. (2012) · Zeitschrift für Gerontologie und Geriatrie · doi:10.1007/s00391-011-0282-2 · Cited by 4
Venken, K., Boonen, S., Bouillon, R., & Vanderschueren, D. (2008) · Wiley eBooks · doi:10.1002/9780470623992.ch24 · Cited by 3
Hormone Actions in the Regulation of Calcium and Phosphorus Metabolism
Ontjes, D. A. (2011) · CRC Press eBooks · doi:10.1201/b11228-8 · Cited by 2
Androgens and Skeletal Biology
Wiren, K. M. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-415853-5.00015-7 · Cited by 2
Androgen Action in Bone: Basic Cellular and Molecular Aspects
Wiren, K. M. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-459-9_16 · Cited by 2
The antiosteoporotic effect of oxymatrine compared to testosterone in orchiectomized rats
Shaban, A. M., Ali, E. A., Tayel, S. G., Rizk, S. K., & Agamy, D. F. E. (2025) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-024-05344-0 · Cited by 2
Çetin, Z., Berker, D. S., Okudan, B., Kılınçkaya, M. F., Turhan, T., & Çatak, M. (2020) · Gynecological Endocrinology · doi:10.1080/09513590.2020.1754786 · Cited by 2
Androgens and Skeletal Biology: Basic Mechanisms
Wiren, K. M. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-375098-3.50016-0 · Cited by 1
Dowling, B., Forsyth, J. J., Zumwalt, M. A., & Robert-McComb, J. J. (2023) · Springer eBooks · doi:10.1007/978-3-031-15485-0_4 · Cited by 1
Komrakova, M., Brunnert, F. N., Christian, A., Böker, K. O., Schilling, A. F., Roch, P. J., Hoffmann, D. B., Lehmann, W., & Sehmisch, S. (2026) · Calcified Tissue International · doi:10.1007/s00223-026-01585-9 · Cited by 1
Bone health and the exercising female
Forsyth, J. J., & Hind, K. (2018) · Routledge eBooks · doi:10.4324/9781351200271-7 · Cited by 1
Clinical effects of cross-sex hormone therapy in adult trans persons
Wierckx, K. (2014) · Ghent University Academic Bibliography (Ghent University) · Cited by 1
(2006) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/01.med.0000202323.44809.4f
The interrelationship of sex steroid levels, body composition and bone characteristics in men
Lapauw, B. (2009) · Ghent University Academic Bibliography (Ghent University)
Streckwall, L., Colareda, G. A., Escudero, D. S., Díaz, R. G., & Fernández, J. M. (2025) · Biology · doi:10.3390/biology14060650
Hormonal impacts on stem cell lineages and related signaling pathways
Maity, S., Maity, S., & Pramanick, K. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-18800-8.00020-4
Impacto de andrógenos na diferenciação e atividade de osteoclastos em cultura celular
Pitombo, J. C. P. (2016) · Americanae (AECID Library)
Kularathna, K. D. C. P. (2015) · Minerva Access (University of Melbourne)
坂下, 陽., & Sakashita, A. (2017) · Institutional Repositories DataBase (IRDB)
Metadata
- Authors
- Chen, Q., Kaji, H., Kanatani, M., Sugimoto, T., & Chihara, K.
- Affiliations
- Kobe University (JP)
- Venue
- Hormone and Metabolic Research
- Publisher
- Georg Thieme Verlag KG
- Published
- 2004-10
- Volume
- 36
- Issue
- 10
- Pages
- 674-678
- ISSN
- 0018-5043 (ISSN-L)
- 1439-4286
- OpenAlex
- W2033198413
- Cited by
- 67
- References
- 0
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 1 · 2023: 4 · 2022: 2 · 2021: 1 · 2020: 1 · 2019: 4 · 2017: 2 · 2016: 2 · 2015: 2 · 2014: 3 · 2013: 3 · 2012: 6
- FWCI
- 1.53
- Type
- journal article
- Language
- de
- Open access
- closed
- Locations
- Hormone and Metabolic Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- testosterone, osteoprotegerin, RANKL, androgen receptor, osteoblasts, bone metabolism, parathyroid hormone, 1,25-dihydroxyvitamin D3, osteoclastogenesis, MC3T3-E1 cells
- MeSH terms
- Animals, Cells, Cultured, Gene Expression Regulation, Glycoproteins, Mice, Inbred ICR, Osteoblasts, RNA, Messenger, Testosterone, Receptors, Tumor Necrosis Factor, Receptors, Cytoplasmic and Nuclear, Mice, Osteoprotegerin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.